Alnylam Pharmaceuticals Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

ALNY
Alnylam Pharmaceuticals

Last Price:

246.56

Seasonality Move:

10.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Alnylam Pharmaceuticals Stock Forecast

Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 40.9% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Alnylam Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 40.9% based on the past 20 years of stock performance.

Alnylam Pharmaceuticals Stock Rating

Sell

Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals overpriced?

Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Alnylam Pharmaceuticals Stock Price History

Is ALNY stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

alnylam.com

52-Week Data

52-Week High:

304.39

52-Week Low:

141.98

Prediction Charts

Market Cap:

32.09B

Price in USD:

248.79

Volume:

1.04M

Beta:

1.20

Technical Analysis

SMA50:

273.13

SMA100:

265.21

SMA200:

210.87

52-Wk Change:

50.54%

Stock Predictions

Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company.
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 248.79 USD today.
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-1	267.05	273.91	274.03	264.00
Nov-4	268.82	269.93	272.92	263.67
Nov-5	268.47	265.29	268.89	264.23
Nov-6	266.21	273.00	278.21	265.52
Nov-7	273.01	272.22	275.07	270.04
Nov-8	271.63	277.43	279.51	270.98
Nov-11	276.10	279.82	286.58	276.10
Nov-12	268.22	268.95	270.77	264.11
Nov-13	269.20	264.47	271.08	264.31
Nov-14	262.18	257.91	262.83	256.75
Nov-15	253.11	235.56	254.17	234.88
Nov-18	235.80	232.27	242.49	229.86
Nov-19	232.19	234.27	235.94	231.23
Nov-20	235.78	248.79	249.10	234.43

Alnylam Pharmaceuticals Earnings

Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Alnylam Pharmaceuticals Forecast Revenue Growth

Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.